marketshareAI

NSCI

NSCIUnknown Sector
0.00%
Market Cap
Volume
0
NaN% of avg
P/E Ratio
N/A
EPS (TTM)
N/A
Beta
N/A
Day Range
p - p
52 Week Range
N/AppN/Ap
p

No data available for this timeframe

NSCI
GOOD

PDS Biotech Advances Versamune® HPV Program, Reports Q2 2024 Results

Biotech company advancing cancer immunotherapy pipeline, reports improved financial results

NSCI
NEUTRAL

NetScientific Announces Annual General Meeting

Venture capital firm NetScientific announces annual report and AGM details

NSCI
NEUTRAL

NetScientific Announces Change in Major Shareholding

Routine regulatory update on change in shareholding for small-cap biotech firm

NSCI
GOOD

NetScientific Director Increases Stake Through SIPP Purchase

Positive news for this small-cap biotech company as a director increases their stake.

NSCI
GOOD

NetScientific Surpasses £100m in Assets Under Management

Venture capital firm grows assets under management to over £100m, driven by expansion of its investment portfolio and investment management activities.

NSCI
NEUTRAL

NetScientific Delays Results Release, Schedules Investor Presentation

NetScientific, a deeptech and life sciences VC investment group, announces a delay in its results release due to successful transactions and auditor constraints.

NSCI
GOOD

NetScientific's DeepTech Recycling Secures £2.1M in Funding, Accelerates Sustainability Initiatives

NetScientific's portfolio company DeepTech Recycling secures £2.1M in funding, accelerating its plastic recycling technology development.

NSCI
GOOD

NetScientific Invests in Wanda Health, Aims to Capitalize on Remote Patient Monitoring Market

NetScientific invests in 30% of Wanda Health, a remote patient monitoring platform, aiming to capitalize on the growing digital healthcare market.

NSCI
GOOD

PDS Biotech Provides Positive Updates on Versamune® HPV Cancer Therapy and Expands IP Portfolio

PDS Biotech, a late-stage immunotherapy company, reports positive updates on its Versamune® HPV cancer therapy and expands its IP portfolio.

NSCI
GOOD

PDS Biotech Announces Promising Clinical Strategy Update and 2023 Financial Results

Biotech firm PDS Biotech reports positive clinical data and financial results